Literature DB >> 11012771

Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes.

A I Roberts1, R S Blumberg, A D Christ, R E Brolin, E C Ebert.   

Abstract

In food poisoning, Staphylococcus aureus secretes staphylococcal enterotoxin B (SEB), a superantigen that causes intense T-cell proliferation and cytotoxicity. The effects of SEB on lytic activity by human intestinal intraepithelial lymphocytes (IEL) were investigated. Jejunal IEL, from morbidly obese individuals undergoing gastric bypass operations, were tested for SEB-induced cytotoxicity against C1R B-lymphoblastoid cells, HT-29 adenocarcinoma cells, or CD1d-transfected cells using the 51Cr-release assay. Fas and Fas ligand expression were detected by immunofluorescence and flow cytometry and soluble ligand by enzyme-linked immunosorbent assay (ELISA). In the presence of SEB, IEL became potently cytotoxic against C1R cells and interferon-gamma (IFN-gamma)-precultured HT-29 cells, causing 55+/-10% and 31+/-6% lysis, respectively, greater than that by phytohaemagglutinin (PHA)-, interleukin-2 (IL-2)-, or anti-T-cell receptor (TCR)-activated IEL. SEB-stimulated peripheral blood (PB) CD8+ T cells lysed similar numbers of C1R cells but fewer HT-29 cells (53+/-13% and 8+/-5%, respectively). IEL killing of C1R cells involved interaction of major histocompatibility complex (MHC) class II with TCR, CD2 with CD58, and CD11a with CD54, and was perforin mediated. SEB-induced IEL lysis of HT-29 cells, in contrast, was caused by an unknown target cell structure, not MHC class II or CD1d, and resulted from a combination of perforin and Fas-mediated events. The potent cytotoxic activities of IEL promoted by SEB utilize two different mechanisms, depending on the surface receptors expressed by the target cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012771      PMCID: PMC2327067          DOI: 10.1046/j.1365-2567.2000.00088.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  In vivo responses of CD4+ and CD8+ cells to bacterial superantigens.

Authors:  T Herrmann; S Baschieri; R K Lees; H R MacDonald
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

2.  Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen.

Authors:  M T Abreu-Martin; A Vidrich; D H Lynch; S R Targan
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

3.  Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects.

Authors:  R Hingorani; I H Choi; P Akolkar; B Gulwani-Akolkar; R Pergolizzi; J Silver; P K Gregersen
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

4.  Activation of T cells by superantigen in class II-negative mice.

Authors:  A C Avery; J S Markowitz; M J Grusby; L H Glimcher; H Cantor
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

5.  Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes.

Authors:  S P Balk; E C Ebert; R L Blumenthal; F V McDermott; K W Wucherpfennig; S B Landau; R S Blumberg
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

6.  Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes.

Authors:  R S Blumberg; C E Yockey; G G Gross; E C Ebert; S P Balk
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

7.  T-cell activation in human intestinal mucosa: the role of superantigens.

Authors:  J Aisenberg; E C Ebert; L Mayer
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

8.  Spontaneous cytotoxicity of intestinal intraepithelial lymphocytes: clues to the mechanism.

Authors:  A I Roberts; S M O'Connell; L Biancone; R E Brolin; E C Ebert
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

9.  Lymphokine-activated killing by human intestinal lymphocytes.

Authors:  E C Ebert; A I Roberts
Journal:  Cell Immunol       Date:  1993-01       Impact factor: 4.868

Review 10.  Composition of TCR-CD3 complex in human intestinal intraepithelial lymphocytes: lack of Fc epsilon RI gamma chain.

Authors:  S P Balk; J E Polischuk; C Probert; C Stevens; E Ebert; J She; C Terhorst; R S Blumberg
Journal:  Int Immunol       Date:  1995-08       Impact factor: 4.823

View more
  7 in total

1.  IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity.

Authors:  Ellen C Ebert
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

2.  Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis.

Authors:  Ping-Chang Yang; Tao Liu; Bin-Quan Wang; Tao-Yuan Zhang; Zi-Yuan An; Peng-Yuan Zheng; Dao-Fa Tian
Journal:  BMC Gastroenterol       Date:  2005-09-06       Impact factor: 3.067

3.  Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes.

Authors:  Marco Donia; Eva Ellebaek; Mads Hald Andersen; Per Thor Straten; Inge Marie Svane
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

4.  Molecular screening of staphylococcal enterotoxin B gene in clinical isolates.

Authors:  Ramezan Ali Ataee; Ali Karami; Morteza Izadi; Aref Aghania; Mohammad Hossein Ataee
Journal:  Cell J       Date:  2011-09-23       Impact factor: 2.479

Review 5.  Staphylococcal enterocolitis: forgotten but not gone?

Authors:  Zheng Lin; Donald P Kotler; Patrick M Schlievert; Emilia Mia Sordillo
Journal:  Dig Dis Sci       Date:  2009-07-16       Impact factor: 3.487

6.  Role of HLA typing on Crohn's disease pathogenesis.

Authors:  Batool Mutar Mahdi
Journal:  Ann Med Surg (Lond)       Date:  2015-08-04

Review 7.  Staphylococcal enterotoxins in the etiopathogenesis of mucosal autoimmunity within the gastrointestinal tract.

Authors:  MaryAnn Principato; Bi-Feng Qian
Journal:  Toxins (Basel)       Date:  2014-04-25       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.